Open this publication in new window or tab >>Molecular Epidemiology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Sweden; Department of Clinical Sciences in Malmö, Lund University, Sweden.
Molecular Epidemiology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Sweden; Division of Family Medicine and Primary Care, Department of Neurobiology, Care Science and Society, Karolinska Institutet, Huddinge, Sweden.
Molecular Epidemiology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Sweden; Preventive Medicine Division, Harvard Medical School, Brigham and Women’s Hospital, Boston, MA.
Molecular Epidemiology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Sweden.
Molecular Epidemiology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Sweden.
Clinical Microbiomics A/S, Copenhagen, Denmark; The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Lyngby, Denmark.
Clinical Microbiomics A/S, Copenhagen, Denmark.
Clinical Microbiomics A/S, Copenhagen, Denmark.
Clinical Microbiomics A/S, Copenhagen, Denmark.
Clinical Microbiomics A/S, Copenhagen, Denmark.
Department of Clinical Sciences in Malmö, Lund University, Sweden.
Department of Clinical Sciences in Malmö, Lund University, Sweden; Clinical Studies Sweden, Forum Söder, Region Skåne, Lund, Sweden.
Department of Clinical Sciences in Malmö, Lund University, Sweden; Section for Clinical Mass Spectrometry, Danish Center for Neonatal Screening, Department of Congenital Disorders, Statens Serum Institut, Copenhagen, Denmark.
Department of Clinical Sciences in Malmö, Lund University, Sweden.
Malmö University, Faculty of Odontology (OD).
Malmö University, Faculty of Odontology (OD). Department of Dental Medicine, Karolinska Institutet, Solna, Sweden.
Department of Clinical Sciences in Malmö, Lund University, Sweden; Department of Internal Medicine, Skåne University Hospital, Malmö, Sweden.
Clinical Physiology, Department of Medical Sciences, Uppsala University, Sweden.
Clinical Epidemiology, Department of Medical Sciences, Uppsala University, Sweden.
Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden; Department of Clinical Physiology, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.
Clinical Epidemiology, Department of Medical Sciences, Uppsala University, Sweden; The George Institute for Global Health, University of New South Wales, Sydney, Australia.
Division of Family Medicine and Primary Care, Department of Neurobiology, Care Science and Society, Karolinska Institutet, Huddinge, Sweden; School of Health and Social Studies, Dalarna University, Falun, Sweden.
Department of Clinical Sciences in Malmö, Lund University, Sweden.
The Wallenberg Laboratory/Department of Molecular and Clinical Medicine, Institute of Medicine, Gothenburg University, Sweden.
Department of Clinical Sciences in Malmö, Lund University, Sweden.
Molecular Epidemiology and Science for Life Laboratory, Department of Medical Sciences, Uppsala University, Sweden.
Show others...
2023 (English)In: Circulation, ISSN 0009-7322, E-ISSN 1524-4539, Vol. 148, no 6, p. 459-472Article in journal (Refereed) Published
Abstract [en]
BACKGROUND: Gut microbiota have been implicated in atherosclerotic disease, but their relation with subclinical coronary atherosclerosis is unclear. This study aimed to identify associations between the gut microbiome and computed tomography–based measures of coronary atherosclerosis and to explore relevant clinical correlates.
METHODS: We conducted a cross-sectional study of 8973 participants (50 to 65 years of age) without overt atherosclerotic disease from the population-based SCAPIS (Swedish Cardiopulmonary Bioimage Study). Coronary atherosclerosis was measured using coronary artery calcium score and coronary computed tomography angiography. Gut microbiota species abundance and functional potential were assessed with shotgun metagenomics sequencing of fecal samples, and associations with coronary atherosclerosis were evaluated with multivariable regression models adjusted for cardiovascular risk factors. Associated species were evaluated for association with inflammatory markers, metabolites, and corresponding species in saliva.
RESULTS: The mean age of the study sample was 57.4 years, and 53.7% were female. Coronary artery calcification was detected in 40.3%, and 5.4% had at least 1 stenosis with >50% occlusion. Sixty-four species were associated with coronary artery calcium score independent of cardiovascular risk factors, with the strongest associations observed for Streptococcus anginosus and Streptococcus oralis subsp oralis (P<1×10–5). Associations were largely similar across coronary computed tomography angiography–based measurements. Out of the 64 species, 19 species, including streptococci and other species commonly found in the oral cavity, were associated with high-sensitivity C-reactive protein plasma concentrations, and 16 with neutrophil counts. Gut microbial species that are commonly found in the oral cavity were negatively associated with plasma indole propionate and positively associated with plasma secondary bile acids and imidazole propionate. Five species, including 3 streptococci, correlated with the same species in saliva and were associated with worse dental health in the Malmö Offspring Dental Study. Microbial functional potential of dissimilatory nitrate reduction, anaerobic fatty acid β-oxidation, and amino acid degradation were associated with coronary artery calcium score.
CONCLUSIONS: This study provides evidence of an association of a gut microbiota composition characterized by increased abundance of Streptococcus spp and other species commonly found in the oral cavity with coronary atherosclerosis and systemic inflammation markers. Further longitudinal and experimental studies are warranted to explore the potential implications of a bacterial component in atherogenesis.
Place, publisher, year, edition, pages
American Heart Association, 2023
National Category
Cardiology and Cardiovascular Disease
Identifiers
urn:nbn:se:mau:diva-62045 (URN)10.1161/circulationaha.123.063914 (DOI)001048683000002 ()37435755 (PubMedID)2-s2.0-85167471568 (Scopus ID)
2023-08-222023-08-222025-02-10Bibliographically approved